Description
RADIOPHARMACEUTICAL COMPOUNDS, EXTENSION OF SERVICES FROM 01 OCT 2012 - 31 MAR 2013 - DECREASE MOD
Base award description: PROVIDE RADIOPHARMACEUTICALS TO NULCLEAR MEDICINE CLINIC.
Modification chain · 15 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-04-30+$121,068= $121,068
- Mod 12009-09-14+$0= $121,068
- Mod 22009-10-01+$248,205= $369,272
- Mod 32009-12-16-$19,213= $350,059
- Mod 42010-03-04+$1,109= $351,168
- Mod 62010-09-25+$17,000= $368,168
- Mod 72010-09-30+$25,770= $393,938
- Mod 52010-10-01+$250,000= $643,938
- Mod 82011-10-01+$263,230= $907,169
- Mod 92012-02-15-$9,566= $897,602
- Mod 102012-02-17+$93,855= $991,457
- Mod P000112012-09-28+$33,435= $1,024,892
- Mod P000122012-10-01+$270,000= $1,294,892
- Mod P000132012-12-18+$2,254= $1,297,146
- Mod P000142013-08-30-$149,245= $1,147,901
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-04-30 | +$121,068 | $121,068 | PROVIDE RADIOPHARMACEUTICALS TO NULCLEAR MEDICINE CLINIC. |
| Mod 1· EXERCISE AN OPTION | 2009-09-14 | +$0 | $121,068 | PROVIDE RADIOPHARMACEUTICALS TO NUCLEAR MEDICINE CLINIC. |
| Mod 2· FUNDING ONLY ACTION | 2009-10-01 | +$248,205 | $369,272 | PROVIDE RADIOPHARMACEUTICALS TO NUCLEAR MEDICINE CLINIC. |
| Mod 3· FUNDING ONLY ACTION | 2009-12-16 | −$19,213 | $350,059 | RADIOPHARMACEUTICAL COMPOUNDS, DEOBLIGATE UNUSED FY09 FUNDS. |
| Mod 4· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2010-03-04 | +$1,109 | $351,168 | RADIOPHARMACEUTICAL COMPOUNDS. |
| Mod 6· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2010-09-25 | +$17,000 | $368,168 | RADIOPHARMACEUTICAL COMPOUNDS. |
| Mod 7· FUNDING ONLY ACTION | 2010-09-30 | +$25,770 | $393,938 | RADIOPHARMACEUTICAL COMPOUNDS. |
| Mod 5· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2010-10-01 | +$250,000 | $643,938 | RADIOPHARMACEUTICAL COMPOUNDS. |
| Mod 8· EXERCISE AN OPTION | 2011-10-01 | +$263,230 | $907,169 | OT - RADIOPHARMACEUTICAL COMPOUNDS. |
| Mod 9· FUNDING ONLY ACTION | 2012-02-15 | −$9,566 | $897,602 | RADIOPHARMACEUTICAL COMPOUNDS, DEOBLIGATE UNUSED FY11 FUNDS. |
| Mod 10· FUNDING ONLY ACTION | 2012-02-17 | +$93,855 | $991,457 | RADIOPHARMACEUTICAL COMPOUNDS, DEOBLIGATE UNUSED FY11 FUNDS. |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2012-09-28 | +$33,435 | $1,024,892 | RADIOPHARMACEUTICAL COMPOUNDS, INCREASE FUNDS TO COVER EXPENDITURES FOR FY12. |
| Mod P00012· EXERCISE AN OPTION | 2012-10-01 | +$270,000 | $1,294,892 | RADIOPHARMACEUTICAL COMPOUNDS, EXTENSION OF SERVICES FROM 01 OCT 2012 - 31 MAR 2013 |
| Mod P00013· EXERCISE AN OPTION | 2012-12-18 | +$2,254 | $1,297,146 | RADIOPHARMACEUTICAL COMPOUNDS, EXTENSION OF SERVICES FROM 01 OCT 2012 - 31 MAR 2013 |
| Mod P00014· FUNDING ONLY ACTION | 2013-08-30 | −$149,245 | $1,147,901 | RADIOPHARMACEUTICAL COMPOUNDS, EXTENSION OF SERVICES FROM 01 OCT 2012 - 31 MAR 2013 - DECREASE MOD |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NRMNYAAVZ767)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25522N0051 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $7,678 | FY2022 |
| 36C25521N0048 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $145,047 | FY2021 |
| 36C24120N0016 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $368,096 | FY2020 |
| 36C25519N0519 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $134,688 | FY2019 |
| 36C24419P0012 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $30,306 | FY2019 |
| 36C24819N0033 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $125,065 | FY2019 |
Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25616P0619 | BIOCOMPATIBLES, INC. | 256-NETWORK CONTRACT OFFICE 16 | $147,500 | FY2016 |
| VA25616F0536 | RETURNS 'R' US, LLC | 256-NETWORK CONTRACT OFFICE 16 | $0 | FY2016 |
| VA25616E3628 | MCKESSON CORPORATION | 256-NETWORK CONTRACT OFFICE 16 | $17,878,985 | FY2016 |
| VA25616P0541 | MCKESSON PLASMA AND BIOLOGICS LLC | 256-NETWORK CONTRACT OFFICE 16 | $10,851 | FY2016 |
| VA25616P0522 | BIOCOMPATIBLES, INC. | 256-NETWORK CONTRACT OFFICE 16 | $32,000 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA256P0628_3600_-NONE-_-NONE- · retrieved 2026-09-26.